Λίστα αντικειμένων
Results of the international MRC UKALLXII/ECOG E2993 trial. Out of the
1 752 patients who achieved CR, 11·7% underwent autologous and 40·6%
allogeneic transplant, while in CR1. Of the autologous patients, 43·2%
relapsed early and 3·4% relapsed late. However, among the allogeneic
patients, 13·2% relapsed early and only 1·3% late. The five-year overall
survival from relapse was 5·8% and 20% in the early and late relapse
patients respectively. In conclusion, late relapse in adults with ALL is
not uncommon, and is associated with better outcome after relapse
compared to early relapse.
reference: Br J Haematol, 2020 Mar 27
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Vadratsikas
1 752 patients who achieved CR, 11·7% underwent autologous and 40·6%
allogeneic transplant, while in CR1. Of the autologous patients, 43·2%
relapsed early and 3·4% relapsed late. However, among the allogeneic
patients, 13·2% relapsed early and only 1·3% late. The five-year overall
survival from relapse was 5·8% and 20% in the early and late relapse
patients respectively. In conclusion, late relapse in adults with ALL is
not uncommon, and is associated with better outcome after relapse
compared to early relapse.
reference: Br J Haematol, 2020 Mar 27
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Vadratsikas